ABSTRACT Regional cerebral glucose utilization was studied by 2-deoxy['4C]glucose autoradiography in morphine-dependent rats and during naloxone-induced morphine withdrawal. In morphine-dependent rats, glucose utilization was increased compared with naive controls uniformly (23-54%) in hippocampus, dentate gyrus, and subiculum and reduced in frontal cortex, striatum, anterior ventral thalamus, and medial habenular nucleus. On precipitation ofmorphine withdrawal by subcutaneous administration of naloxone at 0.5 mg/kg to morphine-dependent rats, glucose utilization was increased in the central nucleus ofamygdala (51%), lateral mammillary nucleus (40%), lateral habenular nucleus (39%), medial mammillary nucleus (35%), and medial septal nucleus (35%) (all, P < 0.01). Significant increases also occurred in several other limbic structures including interpeduncular nucleus, anterior medial and ventral thalamic nuclei, and lateral septal nucleus. Knowledge of the functional cerebral anatomy of the morphine-withdrawal syndrome should facilitate studies directed toward understanding the molecular mechanisms of opiate withdrawal.
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Abrupt termination of chronic morphine treatment or administration of opiate antagonists to morphine-dependent animals results in a complex withdrawal syndrome composed of both stereotyped behavioral and autonomic features (1, 2) . The behavioral concomitants of morphine withdrawal in rodents include wet dog shakes, jumping or escape attempts, teeth chattering, and abnormal posturing; autonomic features include diarrhea, weight loss, hypothermia, seminal emissions, and ptosis. Although much information has accumulated in recent years regarding the identity and distribution of endogenous opiates (3, 4) and their receptor sites (5, 6) in the central nervous system, there is little knowledge of those areas of the central nervous system critical for expression of the morphine-withdrawal syndrome (7).
The 2-deoxyglucose autoradiographic method of Sokoloff et aL (8) has been of great utility in characterizing functional cerebral anatomy. The physiological activity of neurons requires energy derived from the metabolism of glucose. By mapping regional cerebral glucose utilization, inferences can be made about regional physiological neuronal activity. The method has been used to study a variety of experimental paradigms including the routes ofcentral processing ofperipheral sensory stimuli (9, 10) , the spread of focal seizure activity (11, 12) , central sites ofdrug action (13, 14) , and the consequences ofrestricted brain lesions (15, 16) . In an attempt to characterize the functional cerebral anatomy of morphine withdrawal, we have used the 2-deoxyglucose autoradiographic method to describe relative regional cerebral rates of glucose utilization during naloxoneprecipitated morphine withdrawal in the rat. A preliminary report of this work has appeared as an abstract (17) .
MATERIALS AND METHODS
Preparation of Animals. Male Sprague-Dawley rats weighing 275-325 g were used. On experimental day 1, a single pellet containing 75 mg of morphine as free base was implanted subcutaneously under light ether anesthesia. On day 4, two pellets, each containing 75 mg of morphine as free base, were implanted. On day 7, after being deprived of food for 12 hr, the rats were lightly anesthetized with 2% halothane, the pellets were removed, and a polyethylene cannula was implanted into the right externaljugular vein for subsequent injections. At least 2 hr of recovery time was allowed before injection of naloxone at 0.5 mg/kg subcutaneously to induce morphine withdrawal. Controls consisted of naive rats (n = 5), rats made dependent on morphine but injected on day 7 with normal saline rather than naloxone (morphine dependent; n = 4), and naive rats receiving naloxone at 0.5 mg/kg subcutaneously (n = 3). Five rats were studied during naloxone-induced morphine withdrawal. 200 Aum, mounted on cover glasses, and exposed to Kodak SB-5 x-ray film for exactly 5 days. Selected sections were then taken for thionin staining and densitometry was carried out on the autoradiographs. OD results are expressed as OD ofa given region/OD of the corpus callosum ratios. Mean blood glucose levels (mg/ml; ± SD) during naloxone-precipitated morphine withdrawal were 1.87 ± 0.57; levels in naive rats treated acutely with naloxone were 1.15 ± 0.23 and those in morphine-dependent rats treated acutely with normal saline were 1.66 ± 0.10. Therefore, changes in endogenous blood glucose levels were not likely to independently alter the autoradiographic images in rats during naloxone-precipitated morphine withdrawal.
2-Deoxy
Student's t test was used to determine the significance ofthe differences in glucose utilization between various treatment groups (18) .
RESULTS
Morphine-dependent rats that received naloxone at 0.5 mg/ kg subcutaneously on day 7 rapidly developed a morphine-with-
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The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. drawal syndrome consisting of tachypnea, increased motor activity, wet dog shakes, and diarrhea. The animals vocalized when handled but did not exhibit the "jumping" and "flying" phenomena, behaviors that are thought to be environmentally determined. In contrast, morphine-dependent rats that received normal saline subcutaneously on day 7 remained quiet and alert, exhibiting no apparent abnormal behavior. Likewise, naive rats treated with naloxone at 0.5 mg/kg subcutaneously had no overt behavioral changes.
Regional brain glucose utilization in naive controls, in morphine-dependent rats, and in rats during naloxone-induced morphine withdrawal is summarized in Table 1 . Increased glucose utilization relative to naive controls in morphine-dependent rats not given naloxone was found in the medial, lateral, and magnocellular preoptic areas, bed nucleus of the stria terminalis, parasubiculum, subiculum, medial and lateral entorhi- Results represent mean ± SD of the OD of the region in question/OD of the corpus callosum ratio. Arrows denote those regions in which a statistically significant change occurred and the direction of the change: 1 arrow, P < 0.05; 2 arrows, P < 0.01; 3 arrows, P < 0.001. The morphine-dependent group was compared with the naive control kroup and the morphinewithdrawal group was compared with the morphine-dependent group. nal cortex, CA-1 pyramidal layer and stratum radiatum, perforant path, and dentate gyrus. Glucose utilization was decreased in frontal motor cortex, medial frontal cortex, striatum, medial habenular nucleus, and anterior ventral thalamic nucleus in morphine-dependent rats.
Naloxone-induced morphine withdrawal was associated with increased glucose utilization in anterior thalamic nuclei (paratenial, anterior ventral, and anterior medial), bed nucleus of stria terminalis, central nucleus ofamygdala, medial and lateral septal nuclei, lateral habenular nucleus, medial and lateral mammillary nuclei, interpeduncular nucleus, and nucleus accumbens. Glucose utilization was decreased during morphine withdrawal in the subiculum, medial and lateral entorhinal cortex, CA-1 stratum radiatum, and CA-3 pyramidal layer.
Injection ofnaloxone at 0.5 mg/kg subcutaneously produced no significant changes in regional glucose utilization compared with naive controls (data not shown).
A B Autoradiographs depicting regional glucose utilization during morphine withdrawal are shown in Fig. 1 .
DISCUSSION
The principal finding of this study was that morphine addiction and withdrawal were accompanied by discrete, selective, and highly reproducible changes in regional cerebral glucose utilization. Basically, two major regional patterns of cerebral metabolism appeared during morphine addiction and withdrawal. One general pattern was that of a small increase in metabolism during addiction and a return toward control during withdrawal. This pattern occurred primarily in the hippocampal formation, subiculum, and entorhinal cortex. These structures are stimulated or disinhibited by enkephalins and endorphin (19) (20) (21) (22) I 4 -, the recent observations of relatively high concentrations of opiate "receptors" in the hippocampus (5, 6) . The other general pattern of regional changes in brain metabolism could be characterized as a small reduction or no change during morphine addiction with a moderate to large increase during withdrawal. This pattern was seen in several limbic structures including the central nucleus of the amygdala, several midline anterior thalamic nuclei, the bed nucleus of the stria terminalis, the medial and lateral septal and mammillary nuclei, the lateral habenular nucleus, and the interpeduncular nucleus. Each ofthese structures bears some synaptic proximity to the other. For example, the central nucleus of the amygdala projects via the stria terminalis to both the bed nucleus of the stria terminalis and the lateral hypothalamic area (24) (25) (26) . Some neurons of the lateral hypothalamic area project to the septum, which sends efferents into the stria medullaris joining projections from the bed nucleus of the stria terminalis en route to the habenula (27) . The habenula, in turn, projects back to the central nucleus of the amygdala (28) and via the fasciculus retroflexus to the interpeduncular nucleus (27) . Another major projection ofthe central nucleus of the amygdala is to the preoptic hypothalamus (27, 28) , which sends fibers via the median forebrain bundle to mammillary nuclei, which in turn project principally to anterior thalamic nuclei via the mammillo-thalamic tract (27) . Each of the structures that are metabolically active during morphine withdrawal are closely connected synaptically. Therefore, one or a few of those structures may be directly or primarily activated with secondary increases in metabolism in other structures occurring as a consequence of synaptic connections.
An alternative hypothesis is that each of the structures showing prominent increases in metabolism during morphine withdrawal may be activated independently and directly by manipulation of opiate agonist and antagonist drugs. Extensive mapping studies of both endogenous opiate distribution (3, 4) and opiate receptor binding sites (5, 6 ) are now available. Immunohistochemical maps of enkephalin distribution reveal concentrations in midline thalamic nuclei, the lateral edge of the medial habenula, the central nucleus of the amygdala, and the lateral septum; each of these structures are metabolically active during morphine withdrawal. Enkephalin immunoreactivity is quite low, however, in the mammillary nuclei (which showed increased glucose utilization during withdrawal) and quite high in the globus pallidus (a structure that showed little change in glucose utilization). Thus, there is no clear correlation between those structures that are particularly active during morphine withdrawal and the enkephalin content of the structures. Furthermore, autoradiographic studies of opiate receptor distribution revealed a relatively high density in the interpeduncular nucleus (an active structure during withdrawal) as well as the hippocampus (a structure not activated during withdrawal). Thus, neither endogenous enkephalin content nor opiate receptor density correlate consistently with those regions of brain that are most metabolically active during morphine withdrawal.
Whether anatomical relationships or individual biochemical properties are of primary importance in generating the functional anatomical map of morphine withdrawal, the central nucleus of the amygdala would appear to be a particularly important site. That the amygdala, particularly the central nucleus, is important in expression of morphine withdrawal has been suggested by several lines of evidence: (i) the central nucleus of the amygdala projects widely to the hypothalamus and other limbic structures and its stimulation has been found to elicit behavioral and autonomic manifestations similar to some aspects of the morphine-withdrawal syndrome (26, 29) , (ii) the central nucleus of the amygdala possesses the highest enkephalin content ofany ofthe amygdaloid nuclei (30, 31) , and (iii) local injection of naloxone into the central nucleus of the amygdala in rats made dependent on morphine induced the "jump" sign while injection of naloxone into nearby structures failed to produce evidence of withdrawal (7) . Further, electrolytic lesions of the central nucleus of amygdala markedly attenuated the appearance of the jump sign in response to systemic naloxone administration to dependent animals (7) .
As far as we know, except for a 1976 abstract in which it was reported that glucose utilization is particularly affected in the habenula during morphine withdrawal (32) , this is the first study of regional cerebral glucose utilization during opiate addiction and precipitated withdrawal. Our results serve to focus attention on the role of several lImbic structures, particularly the central nucleus of the amygdala, in production of the behavioral and autonomic properties of opiate withdrawal. With the availability of maps of the functional anatomy of morphine withdrawal, biochemical and pharmacological studies directed toward understanding the molecular mechanisms underlying opiate withdrawal should be facilitated.
